quakerbio.com
Quaker Partners
http://www.quakerbio.com/portfoliocompanies.html
New Haven, CT. Innovative biopharmaceutical company dedicated to bringing important new treatments to patients with infectious disease. Developing small molecule, orally active drugs to treat lysosomal storage disorders using pharmacological chaperones to selectively bind and "rescue" misfolded target proteins. Advanced computational fragment-based drug design technology for lead generation and optimization. King of Prussia, PA. Acquired by Pfizer in February 2007. Chapel Hill, NC. Developing novel treat...
quakerbioventures.com
Quaker Partners
http://www.quakerbioventures.com/portfoliocompanies.html
New Haven, CT. Innovative biopharmaceutical company dedicated to bringing important new treatments to patients with infectious disease. Developing small molecule, orally active drugs to treat lysosomal storage disorders using pharmacological chaperones to selectively bind and "rescue" misfolded target proteins. Advanced computational fragment-based drug design technology for lead generation and optimization. King of Prussia, PA. Acquired by Pfizer in February 2007. Chapel Hill, NC. Developing novel treat...
espequity.com
ESP Equity LLC
http://www.espequity.com/investment.html
The Partners of ESP Equity have been working together in an entrepreneuring environment for the last 7 years and most recently build a specialty pharma company from zero to $ 100MM in revenue and sold for more than $500 MM dollars. We are entrepreneur-turned investors and understand opportunity, timing and the needs of entrepreneurs at different stages of the company development. Quality of Company Management. Operations in a niche market with large growth potential. Creative deal structuring to satisfy ...
espequity.com
ESP Equity LLC
http://www.espequity.com/portfolio.html
Is a leading specialty pharmaceutical company in US focused on identifying, fostering and targeting the growth of products to serve the needs of the acute-care hospital setting. Its lead products include Cardene IV, Cardene RTU bag, Retavase, Gelclair, Depodur, etc. The company was acquired by Cornerstone Therapeutics(Nasdaq:TRCX) for $150 million dollars. And other leading western pharmaceutical companies. Indochina Healthcare Limited (IHL). A specialty pharmaceutical company founded in 2002, voted Top ...
espequity.com
ESP Equity LLC
http://www.espequity.com/UC.html
Information Service Solutions (ISS) has supported ESP Equity Partners since its formation. ISS is an IT outsourcing company located in central New Jersey, It serves pharmaceutical, financial and auto-mobile industries and specializes in the enterprise information portal design and system integration, for more detailed info please visit website: http:/ www.issolution.com.
espequity.com
ESP Equity LLC
http://www.espequity.com/index.html
ESP Equity Partners LLC is a private equity investment company working closely with experienced local management teams to acquire pharmaceutical and medical assets in targeted therapeutic areas. ESP Equity is led by successful healthcare entrepreneurs with extensive international experience and a track record of sourcing undervalued products and executing deals in the US, Asia and South America. A leading Canadian pharmaceutical company. May 14, 2012. July 14, 2011. September 28, 2010. New Study Demonstr...
espequity.com
ESP Equity LLC
http://www.espequity.com/news.html
May 14, 2012. Cornerstone Therapeutics to Acquire EKR Therapeutics for $150 million dollars. July 14, 2011. EKR Therapeutics Featured on the Global Learning Series Television Series for Fall and Winter Season. September 28, 2010. New Study Demonstrates Ready-to Use Cardene I.V. More Effective than Labetalol for Immediate Control of Blood Pressure in Emergency Room Patients. February 16, 2010. November 20, 2009. EKR Therapeutics Named Private Company of the Year By New Jersey Technology Council. EKR Thera...
espequity.com
ESP Equity LLC
http://www.espequity.com/team.html
S Douglas Sheldon, Partner. Dr Jeffery Z. Li, Partner. Howard Weisman, Partner. Hiro Iwasaki, Venture Partner. S Douglas. Sheldon is a co-founder and Managing Partner of ESP Equity Partners, LLC. And ESP Chinapharma (Beijing) , a specialty pharma company . Dr Jeffery Z. Li Partner. Dr Li holds a Doctor of Science from Harvard, an MBA from the University of Michigan and a BS in Biology and a BS in Physics from Tsinghua University in Beijing, China. He went on to become the Senior Director of Strategic Par...
quakerpartners.com
Quaker Partners
http://www.quakerpartners.com/portfoliocompanies.html
New Haven, CT. Innovative biopharmaceutical company dedicated to bringing important new treatments to patients with infectious disease. Developing small molecule, orally active drugs to treat lysosomal storage disorders using pharmacological chaperones to selectively bind and "rescue" misfolded target proteins. Advanced computational fragment-based drug design technology for lead generation and optimization. King of Prussia, PA. Acquired by Pfizer in February 2007. Chapel Hill, NC. Developing novel treat...